Biodegradable Stents Market Size, Industry Growth Report 2024-2031 | Reva Medical, Arterius Limited, Elixir Medical Corporation, Kyoto Medical Planning Co, Terumo Corporation

Biodegradable Stents Market is estimated to grow at a CAGR of 5% during the forecast period 2024-2031.

The Biodegradable Stents Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/biodegradable-stents-market?sg

Biodegradable Stents Market Overview:

Biodegradable stents are medical devices made from bioresorbable polymers or metals designed to treat or remove blockages in arteries or biliary ducts. Unlike traditional permanent stents, these stents gradually dissolve or are absorbed by the body over time, reducing long-term complications associated with permanent implants. Biodegradable stents are used in both vascular interventions, such as coronary artery treatments, and nonvascular applications, including biliary duct procedures. Their temporary support structure and ability to eliminate the need for a second removal procedure make them a promising innovation in minimally invasive therapies.

Biodegradable Stents Market: Shifting Industry Trends:

Rising Product Approvals and Cardiovascular Disease Prevalence Fueling Biodegradable Stents Market Growth

The biodegradable stents market is witnessing robust growth, driven in large part by the increasing number of regulatory approvals for innovative products. These approvals are expanding the availability of advanced treatment options and reinforcing the clinical confidence in biodegradable stent technologies.

For example, in February 2019, Biotronik received FDA approval for its Orsiro drug-eluting stent (DES) system, the first ultrathin DES to demonstrate superior performance over the widely used Xience stent. Earlier, in July 2016, the FDA approved the Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), the first fully absorbable stent for coronary artery disease. This device releases everolimus to prevent scar tissue formation and is fully absorbed by the body within approximately three years. That same year, Abbott Laboratories gained approval in Japan for its Absorb bioresorbable heart stent, further expanding global access to next-generation cardiovascular treatments.

In parallel, the rising global burden of cardiovascular diseases (CVDs) is further accelerating demand. According to the World Health Organization (WHO), an estimated 17.9 million deaths in 2016 were attributed to CVDs, accounting for 31% of all global deaths, with 85% resulting from heart attacks and strokes. In Australia alone, the Heart Foundation reported 43,477 CVD-related deaths in 2017, underscoring the disease's significant health impact.

Together, the growing prevalence of CVD and the continuous stream of regulatory approvals for bioresorbable stents are expected to drive sustained growth in this evolving segment of the cardiovascular market.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/biodegradable-stents-market?sg

Strategic Key Players Driving the Biodegradable Stents Market Forward: Boston Scientific Corporation, Arterius Limited, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd, Terumo Corporation, Abbott Laboratories Inc., Amaranth Medical, and Biotronik, Meril Life Sciences Pvt. Ltd, Reva Medical.

Research Methodology:

The global Biodegradable Stents Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Biodegradable Stents Market:

By Product Type (Coronary Artery Stents, Peripheral Artery Stents)

By Material (Polymer-based stents, Metallic Stents, Others)

By End-Users (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgery Centers)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Latest Developments:

✅ Launch & clinical use: In early July 2025, the first patients received a novel regenerative biodegradable stent from Eindhoven University of Technology spin-off STENTiT. This marks an important milestone in moving from concept to clinical application

✅ QualiMed (part of Q3 Medical group) received CE mark approval for the UNITY‐B balloon-expandable biodegradable biliary stent.

Regional Analysis for Biodegradable Stents Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Biodegradable Stents Market Research Industry:

➠ Who leads the Biodegradable Stents industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Biodegradable Stents market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Biodegradable Stents market growth?

➠ What are the dominant sales and distribution strategies in the Biodegradable Stents industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.